EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025

Rhea-AI Summary

EDAP (Nasdaq: EDAP) will release third quarter 2025 financial results for the period ended September 30, 2025, before market open on Thursday, November 6, 2025.

The company will host a conference call and webcast on November 6, 2025 at 8:30 am EST featuring Ryan Rhodes (CEO), Ken Mobeck (CFO), and François Dietsch (Chief Accounting Officer). Domestic and international dial-in numbers and a webcast registration link are provided for investor access.

EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025

Company to host conference call and webcast on Thursday, November 6^th at 8:30am EST

AUSTIN, Texas, October 23, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the third quarter ended September 30, 2025, before the markets open on Thursday, November 6^th, 2025.

An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.

Call Details:

Date:                Thursday, November 6^th

Time:                8:30 am EST

Domestic:          1-800-274-8461

International:      1-203-518-9814

Passcode:          EDAP

Webcast:           https://viavid.webcasts.com/starthere.jsp?ei=1738018&tp_key=c91765d4a0

About EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One^® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

FAQ

When will EDAP (Nasdaq: EDAP) announce Q3 2025 results?

EDAP will release Q3 2025 results before markets open on Thursday, November 6, 2025.

What time is EDAP's Q3 2025 conference call and webcast on November 6, 2025?

The conference call and webcast begin at 8:30 am EST on November 6, 2025.

Who will speak on EDAP's November 6, 2025 earnings call?

Speakers are Ryan Rhodes (CEO), Ken Mobeck (CFO), and François Dietsch (Chief Accounting Officer).

How can investors join EDAP's Q3 2025 webcast?

Register or join via the webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1738018&tp_key=c91765d4a0.

What are the dial-in numbers for EDAP's November 6, 2025 call?

Domestic dial-in: 1-800-274-8461; International dial-in: 1-203-518-9814; passcode: EDAP.

Will EDAP release Q3 2025 financial details during the call or before the market opens?

EDAP will release the Q3 2025 financial results before markets open, with a conference call and webcast following at 8:30 am EST.